197 related articles for article (PubMed ID: 16721639)
21. Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy.
Cheng HL; Lopez V; Lam SC; Leung AKT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; De Ng TR; Suen LKP; Chan CW; Yorke J; Molassiotis A
Health Qual Life Outcomes; 2020 Jul; 18(1):246. PubMed ID: 32703223
[TBL] [Abstract][Full Text] [Related]
22. [Detection of late ototoxic side effect of cisplatin by distortion otoacoustic emission (DPOAE)].
Biró K; Noszek L; Prekopp P; Nagyiványi K; Géczi L; Gaudi I; Bodrogi I
Magy Onkol; 2006; 50(4):329-35. PubMed ID: 17216007
[TBL] [Abstract][Full Text] [Related]
23. Impact of oxaliplatin-induced neuropathy: a patient perspective.
Bennett BK; Park SB; Lin CS; Friedlander ML; Kiernan MC; Goldstein D
Support Care Cancer; 2012 Nov; 20(11):2959-67. PubMed ID: 22426503
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
Kanda K; Fujimoto K; Mochizuki R; Ishida K; Lee B
BMC Cancer; 2019 Sep; 19(1):904. PubMed ID: 31506070
[TBL] [Abstract][Full Text] [Related]
25. Abdominal visceral and subcutaneous fat increase, insulin resistance and hyperlipidemia in testicular cancer patients treated with cisplatin-based chemotherapy.
Willemse PM; van der Meer RW; Burggraaf J; van Elderen SG; de Kam ML; de Roos A; Lamb HJ; Osanto S
Acta Oncol; 2014 Mar; 53(3):351-60. PubMed ID: 23957624
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise.
Amiri A; Chovanec M; Oliva V; Sedliak M; Mego M; Ukropec J; Ukropcová B
Andrology; 2021 Nov; 9(6):1879-1892. PubMed ID: 34245663
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer C; Berger CC; Kuczyk MA; Schmoll HJ
J Clin Oncol; 1996 Nov; 14(11):2923-32. PubMed ID: 8918489
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
[TBL] [Abstract][Full Text] [Related]
29. Paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Brydøy M; Fosså SD; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Dahl O;
Eur Urol; 2010 Jul; 58(1):134-40. PubMed ID: 20395037
[TBL] [Abstract][Full Text] [Related]
30. Editorial comment on: paternity and testicular function among testicular cancer survivors treated with two to four cycles of cisplatin-based chemotherapy.
Salonia A
Eur Urol; 2010 Jul; 58(1):140-1. PubMed ID: 20395038
[No Abstract] [Full Text] [Related]
31. Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.
Smith EML; Banerjee T; Yang JJ; Bridges CM; Alberti P; Sloan JA; Loprinzi C
Cancer Nurs; 2019; 42(3):179-189. PubMed ID: 29649081
[TBL] [Abstract][Full Text] [Related]
32. Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer.
Dulz S; Asselborn NH; Dieckmann KP; Matthies C; Wagner W; Weidmann J; Seidel C; Oing C; Berger LA; Alsdorf W; Mankichian B; Meyer C; Vetterlein MW; Gild P; Ludwig TA; Soave A; Schriefer P; Becker A; Ahyai SA; Oechsle K; Bokemeyer C; Wagenfeld L; Fisch M; Hartmann M; Chun FK; Kluth LA
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1319-1325. PubMed ID: 28281024
[TBL] [Abstract][Full Text] [Related]
33. Long-term ototoxicity in women after cisplatin treatment for ovarian germ cell cancer.
Skalleberg J; Solheim O; Fosså SD; Småstuen MC; Osnes T; Gundersen POM; Bunne M
Gynecol Oncol; 2017 Apr; 145(1):148-153. PubMed ID: 28202195
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
[TBL] [Abstract][Full Text] [Related]
35. The personality trait of neuroticism is strongly associated with long-term morbidity in testicular cancer survivors.
Grov EK; Fosså SD; Bremnes RM; Dahl O; Klepp O; Wist E; Dahl AA
Acta Oncol; 2009; 48(6):842-9. PubMed ID: 19412812
[TBL] [Abstract][Full Text] [Related]
36. Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancer.
Berger CC; Bokemeyer C; Schneider M; Kuczyk MA; Schmoll HJ
Eur J Cancer; 1995 Dec; 31A(13-14):2229-38. PubMed ID: 8652248
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.
Trendowski MR; Wheeler HE; El-Charif O; Feldman DR; Hamilton RJ; Vaughn DJ; Fung C; Kollmannsberger C; Einhorn LH; Travis LB; Dolan ME
Clin Cancer Res; 2020 Dec; 26(24):6550-6558. PubMed ID: 32998964
[TBL] [Abstract][Full Text] [Related]
38. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
[TBL] [Abstract][Full Text] [Related]
39. Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients: the introduction of a new measure.
Driessen CM; de Kleine-Bolt KM; Vingerhoets AJ; Mols F; Vreugdenhil G
Support Care Cancer; 2012 Apr; 20(4):877-81. PubMed ID: 22160655
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis.
von Schlippe M; Fowler CJ; Harland SJ
Br J Cancer; 2001 Sep; 85(6):823-6. PubMed ID: 11556831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]